Get the Stockscreener App
25.44
2.94%
-0.77
Septerna Inc stock is traded at $25.44, with a volume of 164.89K.
It is down -2.94% in the last 24 hours and up +32.29% over the past month.
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
See More
Previous Close:
$26.21
Open:
$26.47
24h Volume:
164.89K
Relative Volume:
0.51
Market Cap:
$1.14B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-4.93%
1M Performance:
+32.29%
6M Performance:
+144.38%
1Y Performance:
+12.72%
1-Day Range:
$25.35
$26.49
1-Week Range:
$24.63
$27.49
52-Week Range:
$4.17
$29.73
Septerna Inc Stock (SEPN) Company Profile
Name
Septerna Inc
Sector
Industry
Phone
650-338-3533
Address
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
Compare SEPN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
25.44 | 1.17B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jun-23-25 | Initiated | H.C. Wainwright | Buy |
| Feb-18-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-19-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-19-24 | Initiated | JP Morgan | Overweight |
| Nov-19-24 | Initiated | TD Cowen | Buy |
| Nov-19-24 | Initiated | Wells Fargo | Overweight |
View All
Septerna Inc Stock (SEPN) Latest News
Strength Seen in Septerna, Inc. (SEPN): Can Its 7.0% Jump Turn into More Strength? - MSN
Will Septerna Inc. stock continue dividend increasesJuly 2025 Fed Impact & Smart Money Movement Tracker - Newser
Septerna, Inc. $SEPN Shares Sold by Sio Capital Management LLC - MarketBeat
What hedge fund activity signals for Septerna Inc. stockPortfolio Return Summary & Low Drawdown Momentum Ideas - Newser
Novo Nordisk Inks $2.2B Deal With Septerna: Retail’s Thrilled - MSN
Septerna (SEPN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Can Septerna Inc. stock beat market expectations this quarterQuarterly Performance Summary & Accurate Trade Setup Notifications - Newser
Septerna plunges as safety concerns force an end to early-stage trial - MSN
Septerna, Inc. $SEPN Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
There is no doubt that Septerna Inc (SEPN) ticks all the boxes. - Setenews
Septerna to Participate in 8th Annual Evercore Healthcare Conference - The Manila Times
Septerna (Nasdaq: SEPN) set for fireside chat at 8th Annual Evercore Healthcare Conference - Stock Titan
Septerna's Novo Partnership Begins To Transform The Story (NASDAQ:SEPN) - Seeking Alpha
Septerna Inc stock hits all-time high at 29.06 USD By Investing.com - Investing.com India
Septerna Inc stock hits all-time high at 29.06 USD - Investing.com
Septerna, Inc. (SEPN) Analyst insights, Price targets and Recommendations - Yahoo Finance Australia
Septerna (SEPN) Is Up 9.9% After Swinging to Q3 Profit and Revenue Surge – Has the Bull Case Changed? - simplywall.st
Cantor Fitzgerald maintains Overweight rating on Septerna stock at $25 By Investing.com - Investing.com Nigeria
Cantor Fitzgerald maintains Overweight rating on Septerna stock at $25 - Investing.com India
Is Septerna Inc. stock affected by interest rate hikesMarket Performance Recap & Real-Time Volume Surge Alerts - newser.com
Septerna (NASDAQ:SEPN) Stock Price Up 6.7%Here's Why - MarketBeat
What is the fair value of Septerna Inc. stock nowGDP Growth & Reliable Momentum Entry Alerts - newser.com
Statistical indicators supporting Septerna Inc.’s strengthJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - newser.com
How to recover losses in Septerna Inc. stockMarket Growth Review & Accurate Technical Buy Alerts - newser.com
Will Septerna Inc. stock rally after Fed decisionsTrade Entry Report & Weekly Chart Analysis and Guides - newser.com
Why analysts upgrade Septerna Inc. stockMarket Sentiment Review & Safe Capital Growth Stock Tips - newser.com
Trend analysis for Septerna Inc. this weekShort Setup & Real-Time Volume Triggers - newser.com
Septerna (SEPN) Price Target Increased by 20.29% to 28.22 - MSN
Septerna, Inc.Common Stock (NQ: SEPN - Markets Financial Content
Pattern recognition hints at Septerna Inc. upsideJuly 2025 Drop Watch & Low Drawdown Trading Techniques - newser.com
Why Septerna (SEPN) Is Up 28.5% After Posting a Surprise Profit and Analyst Upgrades - Yahoo Finance
Is Septerna Inc. stock ready for a breakout2025 Momentum Check & Weekly Return Optimization Alerts - newser.com
Wells upgrades Septerna to Overweight on 2026 share catalysts - MSN
How to monitor Septerna Inc. with trend dashboards2025 Market Trends & Growth Focused Stock Pick Reports - newser.com
Septerna Inc Stock (SEPN) Financials Data
There is no financial data for Septerna Inc (SEPN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):